Advanced Cell Diagnostics公司 Advanced Cell Diagnostics代理 Advanced Cell Diagnostics**代理 Advanced Cell Diagnostics中国代理
ACD shortens the path to personalized medicine by unlocking the power of RNA biomarkers. RNAscope®---快速检测RNA表达原位杂交的新技术 Advanced Cell Diagnostics (以下简称ACD)公司*新推出的RNAscope是一种新型 RNA原位杂交技术,基于其独特的探针设计与背景抑制技术,并且融合传统RNA原位杂交技术与FISH技术的优点,使单个RNA的转录变得可视化,是目前*精准的RNA检测技术。
Advanced Cell Diagnostics, Inc. (ACD) is a leader in the emerging field of molecular pathology, developing cell- and tissue-based diagnostic tests for personalized medicine. based in the heart of Silicon Valley, ACD was founded and managed by experienced entrepreneurs in the life science industry.
ACD’s products and services are based on its proprietary RNAscope® Technology, the first multiplex fluorescent and chromogenic in situ hybridization platform capable of detecting and quantifying RNA biomarkers in situ at single molecule sensitivity.
In addition to its ongoing efforts to develop proprietary diagnostic tests for cancer management, ACD also establishes partnerships with pharmaceutical and biotechnology companies to validate biomarkers for targeted therapeutic development. These internal and external efforts will continue to position ACD as a leader in molecular diagnostics and companion diagnostics.
The company’s technology overcomes critical hurdles in the identification and validation of biomarkers for companion diagnostics. ACD’s RNAscope® platform provides a new way of localizing and measuring RNA in situ with exceptional levels of sensitivity, specificity, and the ability to multiplex. Turnaround time for a new assay is reduced to three weeks. These advantages make the technology a powerful tool to address the issue of patient and disease heterogeneity, thus shortening the path to personalized medicine.
RNAscope试剂盒特点:
本公司网站所展示销售的产品仅供科研!
沪公网安备 31011202007337号